Back to Search
Start Over
Quercetin ameliorates bone loss in OVX rats by modulating the intestinal flora-SCFAs-inflammatory signaling axis.
- Source :
-
International immunopharmacology [Int Immunopharmacol] 2024 Jul 30; Vol. 136, pp. 112341. Date of Electronic Publication: 2024 May 28. - Publication Year :
- 2024
-
Abstract
- Background: Osteoporosis (OP) is a common systemic skeletal disorder characterized by an imbalance in bone homeostasis, involving increased osteoclastic bone formation and decreased osteoblastic bone resorption. Quercetin is a plant polyphenol that has been found to exhibit various biological activities, including antioxidant, anti-inflammatory, and antimicrobial effects. Previous studies have demonstrated its potential to improve postmenopausal OP, although the exact mechanism remains unclear. This study aims to investigate the anti-osteoporotic mechanism of quercetin based on the "intestinal flora - short-chain fatty acids (SCFAs) - inflammatory" signaling axis.<br />Methods: In this study, we established an ovariectomized (OVX)-induced rat model, quercetin intervention and evaluated the effects on rats following antibiotic (ABX) treatment and fecal microbiota transplantation (FMT). After 6 weeks of intervention, the rats were euthanized, and samples from their femur, tibia, lumbar spine, serum, colon and feces were collected, and bone strength, intestinal flora structure, SCFAs levels and cytokine levels were assessed.<br />Results: Quercetin modulates the intestinal flora by increasing potentially probiotic bacteria (i.e., Lactobacillales, Prevotellaceae, and Blautia) and decreasing potentially pathogenic bacteria (Desulfobacterota, Erysipelotrichales, Romboutsia, and Butyricoccaceae). It also increases SCFAs content and reduces colonic permeability by enhancing tight junction proteins (ZO-1, Occludin). Furthermore, quercetin lowers proinflammatory cytokine levels (LPS, IL-1β, and TNF-α), which enhances bone strength and prevents OVX-induced bone loss.<br />Conclusions: Quercetin may effectively reduce bone loss in OVX rats via the "intestinal flora - SCFAs - inflammatory" signaling pathway.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Female
Rats
Cytokines metabolism
Fecal Microbiota Transplantation
Osteoporosis drug therapy
Disease Models, Animal
Anti-Inflammatory Agents pharmacology
Anti-Inflammatory Agents therapeutic use
Humans
Inflammation drug therapy
Gastrointestinal Microbiome drug effects
Quercetin pharmacology
Quercetin therapeutic use
Fatty Acids, Volatile metabolism
Rats, Sprague-Dawley
Ovariectomy
Signal Transduction drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1878-1705
- Volume :
- 136
- Database :
- MEDLINE
- Journal :
- International immunopharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 38810309
- Full Text :
- https://doi.org/10.1016/j.intimp.2024.112341